Global CAR-T Cell Therapy Market: A Pioneer in the Fight Against Cancer, Expected to Reach 5.9 Billion USD by 2031
The global CAR T cell therapy market is at the forefront of the fight against cancer, providing innovative and promising treatment options for patients. According to recent market reports, the global CAR T cell therapy market generated approximately \$1.9 billion in revenue in 2022, and it is estimated to surge to \$5.9 billion by 2031. This remarkable growth trajectory is projected to have a steady annual compound growth rate (CAGR) of 13.5% from 2023 to 2031. Chimeric Antigen Receptor (CAR) T cell therapy is a groundbreaking form of gene cell therapy that utilizes the body's T cells to target and eliminate cancer cells. Typically, the treatment involves three key steps: genetic modification of T cells, infusion of CAR T cells into the patient's body, and collection of T cells, all working together to combat cancer. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.
Inquire About This Product
basic information
Overview of Segmentation The global CAR-T cell therapy market is classified based on drug type, indications, end-users, and regions. By Drug Type - Axicabtagene ciloleucel - Tisagenlecleucel - Brexucabtagene autoleucel - Others By Indications - Lymphoma - Acute lymphoblastic leukemia - Others By End-Users - Hospitals - Cancer treatment centers Key Companies: - Celgene - Gilead Sciences Inc - Celyad Oncology - Pfizer Inc - Autolus Therapeutics - Sorrento Therapeutics Inc - Bristol-Myers Squibb - Cartesian Therapeutics Inc - Caribou Biosciences Inc - Merck & Co Inc - Novartis AG - Cellectis - Miltenyi Biotech - Juno Therapeutics Inc - Intellia Therapeutics - Bluebird Bio Inc
Price range
Delivery Time
P1
Applications/Examples of results
Our product and industry analysis services provide market research insights on product demand, product adoption rates, and market constraints. We conduct research in fields such as chemicals, semiconductors, metals, and mining. We offer quantitative and qualitative data on market trends, forecasts, size, share, growth factors, and CAGR. We serve many leading companies and provide support to a wide range of players in the Japanese market to achieve the best results. We have helped companies seize opportunities not only in Japan but also in both developed and developing countries (Europe, Middle East, USA). Thanks to the services we provide, various players in the Japanese market have established exemplary positions in global niche markets. This demonstrates the value of the services we have offered throughout Japan. Our advanced research analysis provides solutions for companies to access the best data analysis and market intelligence relevant to their respective markets.
Company information
Our researchers conduct in-depth statistical surveys on the past, present, and future, generating forecasts on future scenarios related to market research reports, analytical insights, and almost every conceivable field relevant to our valued entrepreneurial clients and public institutions. Our analysts, consultants, and associates are experts in their respective fields and have strengthened core work ethics through extensive research and analytical capabilities. We are committed to supporting connections with the ever-evolving landscape of information, knowledge, and wisdom.
![[Research Material] The Global Market for Next-Generation Antibody Therapies](https://image.mono.ipros.com/public/product/image/603/2000833456/IPROS42329308565696880162.jpeg?w=280&h=280)
![[Research Material] Global Market for Radioimmunotherapy](https://image.mono.ipros.com/public/product/image/8a6/2001473331/IPROS48377048943343499336.jpeg?w=280&h=280)
![[Research Material] The Global Market for Peptide Receptor Radionuclide Therapy (PRRT)](https://image.mono.ipros.com/public/product/image/00b/2000833796/IPROS40881816910505410664.jpeg?w=280&h=280)
![[Research Material] The Global Market for Bioidentical Hormone Replacement Therapy](https://image.mono.ipros.com/public/product/image/3a0/2001473163/IPROS43280590853693649085.jpeg?w=280&h=280)
